Patents Assigned to Frontier Medicines Corporation
  • Methods and compounds for targeted autophagy
    Patent number: 11666661
    Abstract: Provided herein, inter alia, are methods and compounds for targeted autophagy.
    Type: Grant
    Filed: March 22, 2019
    Date of Patent: June 6, 2023
    Assignees: The Regents of the University of California, Frontier Medicines Corporation
    Inventors: Daniel K. Nomura, Roberto Zoncu, Carl Ward, Sin Ki Fung, Chris Kumar Varma, Benjamin Fontaine
  • PROCESSING BIOPHYSICAL SCREENING DATA AND IDENTIFYING AND CHARACTERIZING PROTEIN SITES FOR DRUG DISCOVERY
    Publication number: 20220036968
    Abstract: Techniques for characterizing protein candidate sites are provided. Experimental data comprising spectral data from an experimental data source is received. Based on the experimental data, a data set comprising a set of protein candidate sites within one or more proteins is created. For each protein candidate site of the set of protein candidate sites, a feature set characterizing the respective protein candidate site is generated. A characterization of the amenability for drug-discovery for one or more of the protein candidate sites is generated by applying a classifier to the respective feature set for the protein candidate site.
    Type: Application
    Filed: July 29, 2021
    Publication date: February 3, 2022
    Applicant: Frontier Medicines Corporation
    Inventors: Saulo DE OLIVEIRA, Johannes Hermann, Chris Varma
  • PROCESSING BIOPHYSICAL SCREENING DATA AND IDENTIFYING AND CHARACTERIZING PROTEIN SITES FOR DRUG DISCOVERY
    Publication number: 20220036969
    Abstract: Techniques for characterizing protein candidate sites are provided. Experimental data comprising spectral data from an experimental data source is received. Based on the experimental data, a data set comprising a set of protein candidate sites within one or more proteins is created. For each protein candidate site of the set of protein candidate sites, a feature set characterizing the respective protein candidate site is generated. A characterization of the amenability for drug-discovery for one or more of the protein candidate sites is generated by applying a classifier to the respective feature set for the protein candidate site.
    Type: Application
    Filed: July 29, 2021
    Publication date: February 3, 2022
    Applicant: Frontier Medicines Corporation
    Inventors: Saulo DE OLIVEIRA, Johannes Hermann, Chris Varma